mortality/aging
• intravenous infection with encapsulated S. aureus, Reynolds strain, results in 20% death by 6-8 days compared to 0% death in similarly infected wild-type mice
• 50% of mice infected intravenously with unencapsulated S. aureus, strain 3825-4, succumb to infection compared to 0% death in similarly infected wild-type mice
|
immune system
• show a 40-50% reduction in phagocytosis of S.aureus
• comparable levels of internalization of E. coli relative to wild-type
• 60% reduction in the ability to internalize lipoteichoic acid
|
• macrophages treated with S. aureus for 4 hours show a 65-75% decrease in IL-12 secretion as compared with wild-type macrophage
• macrophages treated with lipoteichoic acid demonstrate a 60-70% decrease in IL-12 secretion
|
• macrophages treated with E.coli show a 25% decrease in the secretion of IL-6
|
• macrophages treated with S. aureus for 4 hours show a 65-75% decrease in TNF alpha secretion as compared with wild-type macrophage
• macrophages treated with lipoteichoic acid demonstrate a 60-70% defect in TNF secretion
• macrophages treated with E.coli show a 25% decrease in the secretion of TNF alpha
|
• pericardial and perinephric abscess formation in mice infected intravenously with unencapsulated S. aureus
• perinephric abscess formation in 50% of mice infected intravenously with encapsulated S.aureus
|
• intravenous infection with encapsulated S. aureus, Reynolds strain, results in 20% death by 6-8 days compared to 0% death in similarly infected wild-type mice
• 50% of mice infected intravenously with unencapsulated S. aureus, strain 3825-4, succumb to infection compared to 0% death in similarly infected wild-type mice
|
• mice infected with encapsulated S. aureus, Reynolds strain, develop bacteraemia, resulting in a 3.8 x 10^9 S. aureus colony forming units per milliliter of blood on day
|
cardiovascular system
• 100% of the surviving mice infected intravenously with unencapsulated S. aureus strain 3825-4, develop perinephric and/or pericardial abscesses
|
renal/urinary system
• 50% of the animals infected intravenously with encapsulated S. aureus, Reynolds strain, have perinephric abscess formation whereas only 1 of 10 wild-type mice have an apparent abscess of the kidney
• 100% of the surviving mice infected intravenously with unencapsulated S. aureus strain 3825-4, develop perinephric and/or pericardial abscesses
|
hematopoietic system
• show a 40-50% reduction in phagocytosis of S.aureus
• comparable levels of internalization of E. coli relative to wild-type
• 60% reduction in the ability to internalize lipoteichoic acid
|
cellular
• show a 40-50% reduction in phagocytosis of S.aureus
• comparable levels of internalization of E. coli relative to wild-type
• 60% reduction in the ability to internalize lipoteichoic acid
|